Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,623 | -13,018 | -95,304 | -31,445 | -15,674 |
| Depreciation Amortization | 1,064 | 369 | 10,253 | 8,514 | 5,503 |
| Income taxes - deferred | 1,900 | -222 | -19,152 | -4,675 | -3,247 |
| Accounts receivable | 579 | -1,021 | 3,452 | 5,059 | -157 |
| Accounts payable and accrued liabilities | 3,127 | 752 | -2,032 | 4,312 | 5,206 |
| Other Working Capital | -10,665 | -13,781 | -34,017 | -22,825 | -20,064 |
| Other Operating Activity | 2,965 | 5,715 | 54,084 | -17,130 | -9,509 |
| Operating Cash Flow | $-22,653 | $-21,206 | $-82,716 | $-58,190 | $-37,942 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,211 | 21,420 | -16,803 | -33,021 | -59,113 |
| PPE Investments | 125 | -30 | -178 | -167 | -99 |
| Purchase Sale Intangibles | N/A | N/A | -20,000 | -20,000 | -20,000 |
| Other Investing Activity | 0 | 0 | -20,000 | -20,000 | -20,000 |
| Investing Cash Flow | $30,336 | $21,390 | $-36,981 | $-53,188 | $-79,212 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 143,750 | 143,750 | 143,750 |
| Debt Repayment | N/A | N/A | N/A | -6,190 | N/A |
| Common Stock Issued | 92 | 92 | 3,488 | 3,488 | 3,446 |
| Common Stock Repurchased | N/A | N/A | -27,637 | -27,637 | -27,637 |
| Other Financing Activity | -37 | 0 | -6,942 | -676 | -6,399 |
| Financing Cash Flow | $55 | $92 | $112,659 | $112,735 | $113,160 |
| Exchange Rate Effect | 48 | 29 | -201 | -84 | -93 |
| Beginning Cash Position | 9,325 | 9,325 | 16,564 | 16,564 | 16,564 |
| End Cash Position | 17,111 | 9,630 | 9,325 | 17,837 | 12,477 |
| Net Cash Flow | $7,786 | $305 | $-7,239 | $1,273 | $-4,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,653 | -21,206 | -82,716 | -58,190 | -37,942 |
| Capital Expenditure | -29 | -30 | -178 | -167 | -99 |
| Free Cash Flow | -22,682 | -21,236 | -82,894 | -58,357 | -38,041 |